glp-1 and kidneys Renal effects of receptor agonists tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine Role of GLP-1 Agonists &
Description
GLP-1 receptor agonists, such as semaglutide and tirzepatide , have shown promise in managing PCOS symptoms
Gastrointestinal side effects lead some patients to discontinue treatment, and weight regain after stopping therapy is common
We hypothesised that the metabolite GLP-1(936) (previously believed to be biologically inactive) exerts a direct inhibitory effect on glucagon secretion and that this mechanism becomes impaired in diabetes
This is a prebiotic fiberessentially food for the good bugs
